About NsGene
NsGene is a company based in Ballerup (Denmark) founded in 1999. It operates as a B2B. NsGene has raised $5.14 million across 3 funding rounds from investors including European Union, Neurosearch and Danmarks Eksport- og Investeringsfond. NsGene operates in a competitive market with competitors including Impel NeuroPharma, CraniUS, Cognos Therapeutics, Palyon Medical and Bionxt, among others.
- Headquarter Ballerup, Denmark
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Nsgene A/S
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.14 M (USD)
in 3 rounds
-
Latest Funding Round
$303.63 K (USD), Grant
Feb 01, 2017
-
Investors
European Union
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of NsGene
NsGene has successfully raised a total of $5.14M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $303.63 thousand completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NsGene
NsGene has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Neurosearch and Danmarks Eksport- og Investeringsfond.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provision of financing, loans, equity, and insurance for Danish export and investment activities.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for NsGene
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NsGene
Investment portfolio details for NsGene
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NsGene
Detailed financials for NsGene
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nsgene Comparisons
Peer comparison for NsGene
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NsGene
NsGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Impel NeuroPharma, CraniUS, Cognos Therapeutics, Palyon Medical and Bionxt, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Intranasal delivery technology for CNS diseases is developed.
|
|
| Locked | Locked | Locked |
Drug delivery systems for brain diseases and disorders are developed.
|
|
| Locked | Locked | Locked |
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
|
|
| Locked | Locked | Locked |
Develops implantable drug delivery systems for central nervous system disorders.
|
|
| Locked | Locked | Locked |
Drug formulations and delivery systems for diseases are developed.
|
Detailed competitors of NsGene
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nsgene
Complete news archive for NsGene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NsGene
NsGene was founded in 1999 and raised its 1st funding round 6 years after it was founded.
NsGene is headquartered in Ballerup, Denmark.
NsGene is a funded company, having raised a total of $5.14M across 3 funding rounds to date.
NsGene, founded in 1999 in Ballerup, Denmark, focuses on providing healthcare solutions, advancing biotech innovations, therapeutics, and cns drug delivery. Specializes in drug delivery systems and therapeutics for central nervous system diseases. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
NsGene's top competitors include Impel NeuroPharma, CraniUS and Cognos Therapeutics.
NsGene has 5 investors. Key investors include European Union, Neurosearch, Danmarks Eksport- og Investeringsfond, DKA Capital, and LD Fonde.